enVVeno Medical
NVNO
34 hedge funds and large institutions have $12.9M invested in enVVeno Medical in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 11 closing their positions.
528% more call options, than puts
Call options by funds: $289K | Put options by funds: $46K
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
0.42% less ownership
Funds ownership: 1.12% → 0.69% (-0.42%)
6% less funds holding
Funds holding: 36 → 34 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
26% less capital invested
Capital invested by funds: $17.5M → $12.9M (-$4.62M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$862K |
| 2 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$372K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$336K |
| 4 |
ACM
Altium Capital Management
New York
|
+$227K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.33M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$1.17M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$689K |
| 4 |
HCM
Heights Capital Management
San Francisco,
California
|
-$475K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$390K |
NVNO Hedge Fund Activity: Q4 2024 in Review
34 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2024, worth a combined $12.9M — down 26% from $17.5M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NVNO and 9 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $862K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.33M sold.
- 34 institutional investors held enVVeno Medical (NVNO) as of Q4 2024, down from 36 in Q3 2024.
- Funds reported $12.9M of enVVeno Medical stock for Q4 2024, down 26% quarter-over-quarter.
- 9 funds opened new enVVeno Medical positions in Q4 2024 and 11 closed out, a net change of -2 holders.
- The largest enVVeno Medical buyer in Q4 2024 was JP Morgan Chase, an estimated $862K added.
- The largest enVVeno Medical seller in Q4 2024 was Perceptive Advisors, an estimated $2.33M sold.
Based on aggregated 13F filings for Q4 2024.